Low-Grade Fibromyxoid Sarcoma, from the CureRays guide library.

Low-grade fibromyxoid sarcoma is a slow-growing soft-tissue cancer that looks harmless under the microscope but can quietly return or spread to the lungs many years later, so complete surgery and long-term follow-up are essential.

What it is.

Low-grade fibromyxoid sarcoma (LGFMS) is a rare cancer of the soft tissues — the muscle, fat, and connective tissue beneath the skin. It usually shows up as a slowly enlarging, painless lump deep in the thigh, trunk, shoulder, or arm, often in young and middle-aged adults. Its name captures its deceptive nature: 'low-grade' because the cells look bland and inactive, 'fibromyxoid' because of the mix of fibrous and gel-like (myxoid) tissue. The catch is that despite this innocent appearance, LGFMS can come back at the original site or spread to the lungs years — even a decade or more — after it was first removed. Nearly all cases carry a characteristic gene fusion, most often FUS-CREB3L2, which pathologists can test for to confirm the diagnosis and tell it apart from truly benign lumps.

How radiation treats it.

Radiation damages the DNA inside tumor cells so they can no longer divide, and it is especially useful for killing microscopic cells left behind at the edges of a surgical site. In low-grade fibromyxoid sarcoma, surgery is the main cure, but radiation steps in when the team cannot achieve a wide healthy margin — for example, a tumor wrapped around important structures — or when the cancer recurs. For an isolated lung spread, focused SBRT can eliminate the spot with just a few treatments. Radiation is painless, given as a series of short daily sessions, and leaves no radioactivity behind.

The ways we can treat it.

External-beam radiation (IMRT/IGRT). Image-guided, intensity-modulated beams treat the tumor bed before or after surgery when margins are a concern, shaping the dose to cover at-risk tissue while sparing nearby skin, bone, and joints.

Stereotactic body radiation (SBRT). Delivers a few precise, high doses to an isolated lung metastasis or a small recurrence, controlling it without major surgery.

Proton beam therapy. Protons stop after the target, useful for tumors near the spine or other sensitive structures, or to limit dose in younger patients.

Questions we hear often.

If it's low-grade, why do I need long-term follow-up? Low-grade fibromyxoid sarcoma is unusual: it looks calm under the microscope but can return or spread to the lungs many years — sometimes more than a decade — after surgery. That is why your team keeps watching with periodic imaging rather than discharging you after a couple of clear years.

Do I need radiation or chemotherapy? Most patients are cured by wide surgical removal alone. Radiation is added mainly when clean margins aren't possible or the tumor recurs. Chemotherapy works poorly against this cancer and is rarely used.

What does the gene-fusion test tell me? Nearly all of these tumors carry a FUS-CREB3L2 gene fusion. Finding it confirms the diagnosis and separates LGFMS from harmless lumps it can resemble — which matters because this 'harmless-looking' tumor needs proper surgery and follow-up.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.